======= TRIM33 =======
== Gene Information ==
* **Official Symbol**: TRIM33
* **Official Name**: tripartite motif containing 33
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51592|51592]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UPN9|Q9UPN9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TRIM33&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TRIM33|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605769|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is thought to be a transcriptional corepressor. However, molecules that interact with this protein have not yet been identified. The protein is a member of the tripartite motif family. This motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. Three alternatively spliced transcript variants for this gene have been described, however, the full-length nature of one variant has not been determined. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Acts as an E3 ubiquitin-protein ligase. Promotes SMAD4 ubiquitination, nuclear exclusion and degradation via the ubiquitin proteasome pathway. According to PubMed:16751102, does not promote a decrease in the level of endogenous SMAD4. May act as a transcriptional repressor. Inhibits the transcriptional response to TGF-beta/BMP signaling cascade. Plays a role in the control of cell proliferation. Its association with SMAD2 and SMAD3 stimulates erythroid differentiation of hematopoietic stem/progenitor (By similarity). Monoubiquitinates SMAD4 and acts as an inhibitor of SMAD4-dependent TGF-beta/BMP signaling cascade (Monoubiquitination of SMAD4 hampers its ability to form a stable complex with activated SMAD2/3 resulting in inhibition of TGF- beta/BMP signaling cascade). {ECO:0000250, ECO:0000269|PubMed:10022127, ECO:0000269|PubMed:15820681, ECO:0000269|PubMed:16751102, ECO:0000269|PubMed:19135894}.
|zf-B box|
|PHD|
|Bromodomain|
|co-SMAD binding|
|R-SMAD binding|
|negative regulation of BMP signaling pathway|
|regulation of BMP signaling pathway|
|regulation of transforming growth factor beta receptor signaling pathway|
|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|
|regulation of cellular response to transforming growth factor beta stimulus|
|negative regulation of cellular response to growth factor stimulus|
|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|
|ubiquitin-protein transferase activity|
|regulation of cellular response to growth factor stimulus|
|protein ubiquitination|
|protein modification by small protein conjugation|
|zinc ion binding|
|negative regulation of transcription by RNA polymerase II|
|protein modification by small protein conjugation or removal|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of signal transduction|
|negative regulation of RNA metabolic process|
|negative regulation of cell communication|
|negative regulation of signaling|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of response to stimulus|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|-2.45|
|[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|-2.43|
|[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|-2.34|
|[[:results:exp29|Rapamycin 1μM R00 exp29]]|-2.2|
|[[:results:exp30|Rapamycin 10μM R00 exp30]]|-2.08|
|[[:results:exp306|Rapamycin 2μM R07 exp306]]|-1.84|
|[[:results:exp400|Senexin-A 25μM R07 exp400]]|-1.74|
|[[:results:exp512|Olaparib 4μM R08 exp512]]|1.75|
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|1.82|
|[[:results:exp103|Taxol 0.004μM R03 exp103]]|1.91|
|[[:results:exp460|BML-284 0.09μM R08 exp460]]|2.36|
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|2.91|
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|3.01|
^Gene^Correlation^
|[[:human genes:i:id3|ID3]]|0.555|
|[[:human genes:f:fbxo11|FBXO11]]|0.538|
|[[:human genes:r:runx1|RUNX1]]|0.487|
|[[:human genes:s:ssbp2|SSBP2]]|0.486|
|[[:human genes:m:mtor|MTOR]]|0.478|
|[[:human genes:m:maml1|MAML1]]|0.473|
|[[:human genes:c:cbfb|CBFB]]|0.467|
|[[:human genes:m:med23|MED23]]|0.467|
|[[:human genes:z:znf592|ZNF592]]|0.46|
|[[:human genes:d:dcaf5|DCAF5]]|0.456|
|[[:human genes:c:ctdspl2|CTDSPL2]]|0.452|
|[[:human genes:m:mlst8|MLST8]]|0.45|
|[[:human genes:n:nsd1|NSD1]]|0.449|
|[[:human genes:c:ccdc101|CCDC101]]|0.423|
|[[:human genes:r:rptor|RPTOR]]|0.42|
|[[:human genes:m:mef2c|MEF2C]]|0.416|
|[[:human genes:z:zmym2|ZMYM2]]|0.415|
|[[:human genes:z:zmiz1|ZMIZ1]]|0.412|
|[[:human genes:t:taf5l|TAF5L]]|0.402|
|[[:human genes:a:asb7|ASB7]]|0.401|
|[[:human genes:a:asxl2|ASXL2]]|0.4|
|[[:human genes:t:trmt10a|TRMT10A]]|0.4|
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3211
* **Expression level (log2 read counts)**: 6.7
{{:chemogenomics:nalm6 dist.png?nolink |}}